Video

Q&A with David Milan from Massachusetts General Hospital: Research Helps Raise Awareness for Fibromusclar Dysplasia

Author(s):

Current treatment for fibromuscular dysplasia mainly includes symptom management rather than treating the overall condition. Research is working to find not only the cause of the condition but a more robust treatment option.

Current treatment for fibromuscular dysplasia mainly includes symptom management rather than treating the overall condition. Research is working to find not only the cause of the condition but a more robust treatment option.

David J. Milan, MD, from Massachusetts General Hospital discussed research that is being done for the condition during the American Heart Association's annual meeting in Orlando.

Related Videos
Experts' Perspectives: Top Stories in Cardiology for 2024
Yehuda Handelsman, MD: Insulin Resistance in Cardiometabolic Disease and DCRM 2.0 | Image Credit: TMIOA
Nathan D. Wong, MD, PhD: Growing Role of Lp(a) in Cardiovascular Risk Assessment | Image Credit: UC Irvine
Laurence Sperling, MD: Expanding Cardiologists' Role in Obesity Management  | Image Credit: Emory University
Laurence Sperling, MD: Multidisciplinary Strategies to Combat Obesity Epidemic | Image Credit: Emory University
Matthew J. Budoff, MD: Examining the Interplay of Coronary Calcium and Osteoporosis | Image Credit: Lundquist Institute
Orly Vardeny, PharmD: Finerenone for Heart Failure with EF >40% in FINEARTS-HF | Image Credit: JACC Journals
Matthew J. Budoff, MD: Impact of Obesity on Cardiometabolic Health in T1D | Image Credit: The Lundquist Institute
Matthew Weir, MD: Prioritizing Cardiovascular Risk in Chronic Kidney Disease | Image Credit: University of Maryland
© 2025 MJH Life Sciences

All rights reserved.